CRISPR/Cas9

B-MoGen utilizes the most state of the art technology to precisely modify mammalian cells for research and industry partners. Using CRISPR/Cas9 B-MoGen can quickly and efficiently generate targeted knock-out and knock-in cell lines for academia, pharma and biotech researchers looking to precisely edit their favorite gene in their favorite cell line.